Company Filing History:
6 out of 321 
3 out of 22 
2 out of 10 Years Active: 2017-2021
Title: In Sik Shin: Innovator in Pharmaceutical Composition for Respiratory Diseases
Introduction
In Sik Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). With a total of 7 patents to his name, his work focuses on innovative solutions that aim to improve patient outcomes.
Latest Patents
One of his latest patents is a composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing or treating asthma. This invention relates to a pharmaceutical composition that not only addresses asthma but also serves as a functional health food composition. The monoacetyldiacylglycerol compound inhibits the expression of IL-4 in EL-4 cells, reduces airway hypersensitivity in asthma-induced animal models, and prevents the infiltration of inflammatory cells into the bronchial tubes. Furthermore, it inhibits the generation of IgE in serum and bronchoalveolar lavage fluid, demonstrating an excellent effect on Th2 cytokines, thus overcoming the side effects of currently used therapeutic agents for asthma.
Another significant patent by In Sik Shin involves a composition containing a monoacetyldiacylglycerol compound for preventing or treating chronic obstructive pulmonary disease. This invention also serves as a functional health food composition. The compound inhibits IL-4 expression in EL-4 cells and inflammatory cell infiltration in animal models. It effectively inhibits the expression of CXCL-1, TNF-α, or MIP-2, showcasing its potential to overcome the side effects of existing therapeutic agents for COPD while exhibiting no toxicity.
Career Highlights
In Sik Shin has worked with notable organizations such as the Korea Research Institute of Bioscience and Biotechnology and Enzychem Lifesciences Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
He has collaborated with esteemed colleagues, including Kyung Seop Ahn and Sei Ryang Oh, contributing to the advancement of research in respiratory health.
Conclusion
In Sik Shin's innovative work in pharmaceutical compositions for respiratory diseases highlights his commitment to improving health outcomes. His patents reflect a deep understanding of the mechanisms involved in asthma and COPD, paving the way for more effective treatments.